Background: As Greece is a country which has introduced the 13-valent pneumococcal conjugate vaccine (PCV13) both in the infant and in the adult immunization programs, the aim of the study was to investigate age-specific and serotype-specific trends of pneumococcal meningitis over an 11-year period (2010-2020).
Materials And Methods: Data are reported from pneumococcal meningitis cases [notified to the National Public Health Organization (NPHO)], with clinical samples and bacterial isolates sent for pneumococcal identification and serotyping at the National Meningitis Reference Laboratory (NMRL). Pneumococcal identification was performed directly on clinical samples or bacterial isolates by multiplex PCR (mPCR) assay, while serotyping was carried out by application of the Capsular Sequence Typing (CST) method with the combination of single tube PCR assays.
A case of severe thrombocytopenic purpura as the sole manifestation of brucellosis in an 11-y-old boy is presented. Clinical examination was negative and laboratory tests revealed anemia, leukopenia and severe thrombocytopenia. The initial diagnosis was idiopathic thrombocytopenic purpura and intravenous gamma globulin was given.
View Article and Find Full Text PDF